Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 2
1983 1
1986 3
1987 1
1988 2
1989 2
1991 1
1993 2
1994 2
1995 4
1996 1
1997 3
1998 1
1999 2
2000 8
2001 8
2002 8
2003 6
2004 2
2005 7
2006 4
2007 3
2008 3
2009 4
2010 4
2011 2
2012 4
2013 3
2014 2
2015 1
2016 2
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Erythropoietin and iron.
Sunder-Plassmann G, Hörl WH. Sunder-Plassmann G, et al. Clin Nephrol. 1997 Mar;47(3):141-57. Clin Nephrol. 1997. PMID: 9105761 Review.
However, neutrophil impairment and other possible side-effects (e.g. cardiovascular complications, malignancy) as a result of i.v. iron therapy suggest that overtreatment with i.v. iron should be avoided....
However, neutrophil impairment and other possible side-effects (e.g. cardiovascular complications, malignancy) as a result of i.v. ir …
[Urinary tract infections].
Hörl WH. Hörl WH. Internist (Berl). 2011 Sep;52(9):1026, 1028-31. doi: 10.1007/s00108-011-2861-0. Internist (Berl). 2011. PMID: 21850538 Review. German.
Complicated urinary tract infections associated with anatomical and/or functional abnormalities of the urinary tract and/or comorbidities such as diabetes or immunosuppressive therapy, need longer antibiotic treatment (e.g. 10-14 days) as well as interdisciplinary diagnost …
Complicated urinary tract infections associated with anatomical and/or functional abnormalities of the urinary tract and/or comorbidities su …
Nonsteroidal Anti-Inflammatory Drugs and the Kidney.
Hörl WH. Hörl WH. Pharmaceuticals (Basel). 2010 Jul 21;3(7):2291-2321. doi: 10.3390/ph3072291. Pharmaceuticals (Basel). 2010. PMID: 27713354 Free PMC article. Review.
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the isoenzymes COX-1 and COX-2 of cyclooxygenase (COX). Renal side effects (e.g., kidney function, fluid and urinary electrolyte excretion) vary with the extent of COX-2-COX-1 selectivity and the administered dose of t …
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the isoenzymes COX-1 and COX-2 of cyclooxygenase (COX). Renal side effects (e.g …
Anaemia management and mortality risk in chronic kidney disease.
Hörl WH. Hörl WH. Nat Rev Nephrol. 2013 May;9(5):291-301. doi: 10.1038/nrneph.2013.21. Epub 2013 Feb 26. Nat Rev Nephrol. 2013. PMID: 23438972 Review.
Randomized controlled trials have tested the hypothesis that increasing haemoglobin level using erythropoiesis-stimulating agents (ESAs) lowers these risks and improves quality of life. Use of ESAs to normalize haemoglobin levels (to 130 g/l) versus the partial correction …
Randomized controlled trials have tested the hypothesis that increasing haemoglobin level using erythropoiesis-stimulating agents (ESAs) low …
Effect of erythropoietin on cardiovascular diseases.
Sunder-Plassmann G, Hörl WH. Sunder-Plassmann G, et al. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S20-5. doi: 10.1053/ajkd.2001.27391. Am J Kidney Dis. 2001. PMID: 11576916 Review.
In chronic renal failure patients with severe anemia (hemoglobin levels <10 g/dL), increased cardiac output, high left ventricular mass, left ventricular end-diastolic and end-systolic diameters, and cardiac symptoms improve after partial correction of anemia (hemoglobi …
In chronic renal failure patients with severe anemia (hemoglobin levels <10 g/dL), increased cardiac output, high left ventricular …
Intravenous iron therapy: well-tolerated, yet not harmless.
Sengölge G, Hörl WH, Sunder-Plassmann G. Sengölge G, et al. Eur J Clin Invest. 2005 Dec;35 Suppl 3:46-51. doi: 10.1111/j.1365-2362.2005.01530.x. Eur J Clin Invest. 2005. PMID: 16281958 Review.
In the majority of patients with chronic renal failure, it is essential to substitute erythropoietic agents and iron to maintain a haemoglobin level above 11 g dL-1. Intravenous iron is more effective than oral iron. Substitution of intravenous iron is mainly performed usi …
In the majority of patients with chronic renal failure, it is essential to substitute erythropoietic agents and iron to maintain a haemoglob …
Is there a role for adjuvant therapy in patients being treated with epoetin?
Hörl WH. Hörl WH. Nephrol Dial Transplant. 1999;14 Suppl 2:50-60. doi: 10.1093/ndt/14.suppl_2.50. Nephrol Dial Transplant. 1999. PMID: 10334668 Review.
During the correction phase, a dose of i.v. iron equivalent to 50 mg/day is recommended, with the total dose not exceeding 3 g. When subclinical vitamin C deficiency is suspected, ascorbic acid may be given orally (1-1.5 g/week) or i.v. (300 mg three times weekly at …
During the correction phase, a dose of i.v. iron equivalent to 50 mg/day is recommended, with the total dose not exceeding 3 g. When …
Vitamin C in chronic kidney disease and hemodialysis patients.
Deicher R, Hörl WH. Deicher R, et al. Kidney Blood Press Res. 2003;26(2):100-6. doi: 10.1159/000070991. Kidney Blood Press Res. 2003. PMID: 12771534 Review.
Currently, 60 mg of ascorbate are recommended for chronic kidney disease patients, and 1-1.5 g of oral ascorbate/week in case of suspected subclinical ascorbate deficiency or 300 mg parenteral ascorbate/dialysis session, respectively. ...
Currently, 60 mg of ascorbate are recommended for chronic kidney disease patients, and 1-1.5 g of oral ascorbate/week in case of susp …
[Tumor lysis syndrome: risk factors and treatment].
Hörl WH. Hörl WH. Wien Klin Wochenschr. 2005 Jan;117(1-2):7-17. doi: 10.1007/s00508-005-0318-y. Wien Klin Wochenschr. 2005. PMID: 15986584 Review. German.
Tumor lysis syndrome is a typical oncological complication, characterized by hyperuricemia, hyperkalemia, hyperphosphatemia with secondary hypocalcemia, acidosis and acute renal failure. it occurs particularly in patients with lymphoproliferative diseases during therapy with pote …
Tumor lysis syndrome is a typical oncological complication, characterized by hyperuricemia, hyperkalemia, hyperphosphatemia with secondary h …
Glycolysis without pyruvate kinase in Clostridium thermocellum.
Olson DG, Hörl M, Fuhrer T, Cui J, Zhou J, Maloney MI, Amador-Noguez D, Tian L, Sauer U, Lynd LR. Olson DG, et al. Metab Eng. 2017 Jan;39:169-180. doi: 10.1016/j.ymben.2016.11.011. Epub 2016 Dec 1. Metab Eng. 2017. PMID: 27914869
95 results